ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
GSK decides to halt mid-stage feladilimab studies
April 16, 2021GlaxoSmithKline (GSK) has announced that it will stop enrolling patients into trials evaluating its investigational inducible T cell co-stimulatory (ICOS) agonist feladilimab. -
GSK begins clinical trials of pancreatic cancer combination
December 03, 2018GlaxoSmithKline plans to carry out clinical trials on its pancreatic drug hopeful, GSK547, following promising results when treating mice and laboratory-grown tumour cells.
Pharma Sources Insight January 2025
